BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3301388)

  • 21. In vitro effects of citral on trypanosoma cruzi metacyclogenesis.
    Cardoso J; Soares MJ
    Mem Inst Oswaldo Cruz; 2010 Dec; 105(8):1026-32. PubMed ID: 21225200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarthritic and immunoregulatory activity of spirogermanium.
    DiMartino MJ; Lee JC; Badger AM; Muirhead KA; Mirabelli CK; Hanna N
    J Pharmacol Exp Ther; 1986 Jan; 236(1):103-10. PubMed ID: 2934544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro assessment of antimicrobial agents against Toxoplasma gondii.
    Harris C; Salgo MP; Tanowitz HB; Wittner M
    J Infect Dis; 1988 Jan; 157(1):14-22. PubMed ID: 3121760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological activity of the azlactone derivative EPA-35 against Trypanosoma cruzi.
    de Azeredo CM; Ávila EP; Pinheiro DL; Amarante GW; Soares MJ
    FEMS Microbiol Lett; 2017 Feb; 364(4):. PubMed ID: 28130370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L-proline is essential for the intracellular differentiation of Trypanosoma cruzi.
    Tonelli RR; Silber AM; Almeida-de-Faria M; Hirata IY; Colli W; Alves MJ
    Cell Microbiol; 2004 Aug; 6(8):733-41. PubMed ID: 15236640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppressor cell induction by the anticancer drug spirogermanium.
    Badger AM; DiMartino MJ; Schmitt TC; Swift BA; Mirabelli CK
    Int J Immunopharmacol; 1987; 9(5):621-30. PubMed ID: 2957334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4-Nitrobenzaldehyde thiosemicarbazone: a new compound derived from S-(-)-limonene that induces mitochondrial alterations in epimastigotes and trypomastigotes of Trypanosoma cruzi.
    Britta EA; Scariot DB; Falzirolli H; da Silva CC; Ueda-Nakamura T; Dias Filho BP; Borsali R; Nakamura CV
    Parasitology; 2015 Jun; 142(7):978-88. PubMed ID: 25711881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of monosaccharides on the infection of vertebrate cells by Trypanosoma cruzi and Toxoplasma gondii.
    Crane MS; Dvorak JA
    Mol Biochem Parasitol; 1982 May; 5(5):333-41. PubMed ID: 7048090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo and in vitro effects of cyclosporin A on Trypanosoma cruzi.
    McCabe RE; Remington JS; Araujo FG
    Am J Trop Med Hyg; 1985 Sep; 34(5):861-5. PubMed ID: 3929634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of proteinase inhibitors on the growth and differentiation of Trypanosoma cruzi.
    Franke de Cazzulo BM; Martínez J; North MJ; Coombs GH; Cazzulo JJ
    FEMS Microbiol Lett; 1994 Nov; 124(1):81-6. PubMed ID: 8001773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiproliferative effect and ultrastructural alterations induced by 5-O-methylembelin on Trypanosoma cruzi.
    Spina RM; Lozano E; Barrera PA; Agüero MB; Tapia A; Feresin GE; Sosa MÁ
    Phytomedicine; 2018 Jul; 46():111-118. PubMed ID: 30097111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological and ultrastructural effects of the anti-microtubule agent taxol against Trypanosoma cruzi.
    Dantas AP; Barbosa HS; De Castro SL
    J Submicrosc Cytol Pathol; 2003 Jul; 35(3):287-94. PubMed ID: 14690177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival of Trypanosoma cruzi metacyclic trypomastigotes within Coxiella burnetii vacuoles: differentiation and replication within an acidic milieu.
    Andreoli WK; Taniwaki NN; Mortara RA
    Microbes Infect; 2006 Jan; 8(1):172-82. PubMed ID: 16182585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential Effects of Two Widely Used Solvents, DMSO and Ethanol, on the Growth and Recovery of
    Cevallos AM; Herrera J; López-Villaseñor I; Hernández R
    Korean J Parasitol; 2017 Feb; 55(1):81-84. PubMed ID: 28285511
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of metal containing compounds on superoxide release from phorbol myristate acetate stimulated murine peritoneal macrophages: inhibition by auranofin and spirogermanium.
    Mirabelli CK; Sung CP; Picker DH; Barnard C; Hydes P; Badger AM
    J Rheumatol; 1988 Jul; 15(7):1064-9. PubMed ID: 2845079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decoding the anti-Trypanosoma cruzi action of HIV peptidase inhibitors using epimastigotes as a model.
    Sangenito LS; Menna-Barreto RF; D Avila-Levy CM; Santos AL; Branquinha MH
    PLoS One; 2014; 9(12):e113957. PubMed ID: 25464510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of hydroxyurea and colchicine on growth and morphology of Trypanosoma cruzi.
    Filho SA; Pereira de Almeida ER; Gander ES
    Acta Trop; 1978 Sep; 35(3):229-37. PubMed ID: 31776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrastructural effects of the chelating agent 1,10-phenanthroline on Trypanosoma cruzi epimastigotes in vitro.
    Lane JE; Bogitsh BJ; Ribeiro-Rodrigues R; Kral MV; Jones MM; Carter CE
    Parasitol Res; 1998 May; 84(5):399-402. PubMed ID: 9610638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The activity of ketoconazole and other azoles against Trypanosoma cruzi: biochemistry and chemotherapeutic action in vitro.
    Goad LJ; Berens RL; Marr JJ; Beach DH; Holz GG
    Mol Biochem Parasitol; 1989 Jan; 32(2-3):179-89. PubMed ID: 2494453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of suppressor cells in normal rats by treatment with spirogermanium, a novel heterocyclic anticancer drug.
    Badger AM; Mirabelli CK; DiMartino M
    Immunopharmacology; 1985 Dec; 10(3):201-7. PubMed ID: 2939040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.